182 related articles for article (PubMed ID: 17332311)
1. Excess transmission of the NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia.
Infante-Rivard C; Vermunt JK; Weinberg CR
Am J Epidemiol; 2007 Jun; 165(11):1248-54. PubMed ID: 17332311
[TBL] [Abstract][Full Text] [Related]
2. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements.
Lanciotti M; Dufour C; Corral L; Di Michele P; Pigullo S; De Rossi G; Basso G; Leszl A; Luciani M; Lo Nigro L; Micalizzi C; Valsecchi MG; Biondi A; Haupt R
Leukemia; 2005 Feb; 19(2):214-6. PubMed ID: 15618957
[TBL] [Abstract][Full Text] [Related]
4. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.
Smith MT; Wang Y; Skibola CF; Slater DJ; Lo Nigro L; Nowell PC; Lange BJ; Felix CA
Blood; 2002 Dec; 100(13):4590-3. PubMed ID: 12393620
[TBL] [Abstract][Full Text] [Related]
5. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
Kracht T; Schrappe M; Strehl S; Reiter A; Elsner HA; Trka J; Cario G; Viehmann S; Harbott J; Borkhardt A; Metzler M; Langer T; Repp R; Marschalek R; Welte K; Haas OA; Stanulla M
Haematologica; 2004 Dec; 89(12):1492-7. PubMed ID: 15590400
[TBL] [Abstract][Full Text] [Related]
6. NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis.
Guha N; Chang JS; Chokkalingam AP; Wiemels JL; Smith MT; Buffler PA
Am J Epidemiol; 2008 Dec; 168(11):1221-32. PubMed ID: 18945694
[TBL] [Abstract][Full Text] [Related]
7. The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan.
Eguchi-Ishimae M; Eguchi M; Ishii E; Knight D; Sadakane Y; Isoyama K; Yabe H; Mizutani S; Greaves M
Haematologica; 2005 Nov; 90(11):1511-5. PubMed ID: 16266898
[TBL] [Abstract][Full Text] [Related]
8. NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution.
de Aguiar Gonçalves BA; Vasconcelos GM; Thuler LC; Andrade C; Faro A; Pombo-de-Oliveira MS; ; Emerenciano M; de Camargo B; Bernstain L; Neves CC; Agareno JM; de Carvalho LM; Araújo FN; de Brito NP; Magalhães IQ; Cordoba JC; Pimenta F; Gadelha A; Cartaxo E; Basegio RM; Mnayarji A; Souza MS; Arencibia A; Melaragno R; Cóser VM; Lafayete TC; Koifman S
Cancer Causes Control; 2012 Nov; 23(11):1811-9. PubMed ID: 22976839
[TBL] [Abstract][Full Text] [Related]
9. Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE).
Bonaventure A; Goujon-Bellec S; Rudant J; Orsi L; Leverger G; Baruchel A; Bertrand Y; Nelken B; Pasquet M; Michel G; Sirvent N; Bordigoni P; Ducassou S; Rialland X; Zelenika D; Hémon D; Clavel J
Cancer Causes Control; 2012 Feb; 23(2):329-45. PubMed ID: 22200898
[TBL] [Abstract][Full Text] [Related]
10. Parental occupational exposure to benzene and the risk of childhood and adolescent acute lymphoblastic leukaemia: a population-based study.
Heck JE; He D; Contreras ZA; Ritz B; Olsen J; Hansen J
Occup Environ Med; 2019 Aug; 76(8):527-529. PubMed ID: 31138675
[TBL] [Abstract][Full Text] [Related]
11. The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group.
Stanulla M; Dynybil C; Bartels DB; Dördelmann M; Löning L; Claviez A; Schrappe M;
Haematologica; 2007 Nov; 92(11):1581-2. PubMed ID: 18024413
[TBL] [Abstract][Full Text] [Related]
12. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators.
Wiemels JL; Pagnamenta A; Taylor GM; Eden OB; Alexander FE; Greaves MF
Cancer Res; 1999 Aug; 59(16):4095-9. PubMed ID: 10463613
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of GSTT1, GSTM1 and NQO1 (609C>T) in Filipino children with ALL (acute lymphoblastic leukaemia).
Rimando MG; Chua MN; Yuson Ed; de Castro-Bernas G; Okamoto T
Biosci Rep; 2008 Jun; 28(3):117-24. PubMed ID: 18444911
[TBL] [Abstract][Full Text] [Related]
14. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.
Bolufer P; Collado M; Barragán E; Cervera J; Calasanz MJ; Colomer D; Roman-Gómez J; Sanz MA
Haematologica; 2007 Mar; 92(3):308-14. PubMed ID: 17339179
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies.
Blanco JG; Edick MJ; Hancock ML; Winick NJ; Dervieux T; Amylon MD; Bash RO; Behm FG; Camitta BM; Pui CH; Raimondi SC; Relling MV
Pharmacogenetics; 2002 Nov; 12(8):605-11. PubMed ID: 12439220
[TBL] [Abstract][Full Text] [Related]
16. Parental, In Utero, and Early-Life Exposure to Benzene and the Risk of Childhood Leukemia: A Meta-Analysis.
Carlos-Wallace FM; Zhang L; Smith MT; Rader G; Steinmaus C
Am J Epidemiol; 2016 Jan; 183(1):1-14. PubMed ID: 26589707
[TBL] [Abstract][Full Text] [Related]
17. Molecular biomarkers for the study of childhood leukemia.
Smith MT; McHale CM; Wiemels JL; Zhang L; Wiencke JK; Zheng S; Gunn L; Skibola CF; Ma X; Buffler PA
Toxicol Appl Pharmacol; 2005 Aug; 206(2):237-45. PubMed ID: 15967214
[TBL] [Abstract][Full Text] [Related]
18. Parental smoking, CYP1A1 genetic polymorphisms and childhood leukemia (Québec, Canada).
Infante-Rivard C; Krajinovic M; Labuda D; Sinnett D
Cancer Causes Control; 2000 Jul; 11(6):547-53. PubMed ID: 10880037
[TBL] [Abstract][Full Text] [Related]
19. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review.
Nebert DW; Roe AL; Vandale SE; Bingham E; Oakley GG
Genet Med; 2002; 4(2):62-70. PubMed ID: 11882782
[TBL] [Abstract][Full Text] [Related]
20. Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studies.
Li C; Zhou Y
J Cancer Res Clin Oncol; 2014 Jun; 140(6):873-81. PubMed ID: 24488035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
